Drug Profile
Minocycline - Dr Reddys Laboratories/Journey Medical Corporation
Alternative Names: DFD 10; DFD-29; Minocycline HCl extended release - Dr. Reddy's Laboratories/Promius Pharma/Journey Medical Corporation; Minocycline hydrochloride extended release - Dr Reddy's Laboratories; Minocycline modified release capsules - Dr Reddy's Laboratories; MINOLIRALatest Information Update: 26 Mar 2024
Price :
$50
*
At a glance
- Originator Dr Reddys Laboratories
- Developer Dr Reddys Laboratories; Journey Medical Corporation; Promius Pharma
- Class Amides; Anti-inflammatories; Antiacnes; Antibacterials; Dimethylamines; Eye disorder therapies; Neuroprotectants; Skin disorder therapies; Small molecules; Tetracyclines
- Mechanism of Action Glial cell inhibitors; Interleukin 1 alpha inhibitors; Interleukin-6 modulators; Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Acne vulgaris
- Preregistration Rosacea